Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06582693 · ClinicalTrials.gov registry record · NA
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
A NA study of Smoking Cessation and Smoking, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- NA
- Development phase
- 3,200
- Enrollment target
- 1
- Study location
NCT06582693: Recruiting NA study of Smoking Cessation and Smoking, sponsored by Children's Hospital of Philadelphia.
NCT06582693 is a NA study of Smoking Cessation and Smoking that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 3,200 participants, above the 458-participant average among 188 other Smoking Cessation trials with a reported enrollment target (599% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06582693, a NA study of Smoking Cessation and Smoking, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare the reach and effectiveness of the Refer2Quit intervention for increasing tobacco use treatment and quit rates among household members who smoke versus a treatment as usual group. This clinical trial also aims to study household member and pediatric patient characteristics that are associated with reach and effectiveness of Refer2Quit.
Primary Outcome
The proportion of adult participants who engage in any evidence-based tobacco use treatments, between the intervention and control arms, by adult participant self-report.
Conditions Studied
Interventions
- OTHER Refer2Quit
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,200 participants |
| Start Date | 2024-09-06 |
| Est. Completion | 2027-03-01 |
| Phase | NA |
What NCT06582693 shows while recruiting
NCT06582693 is an interventional study that assigns participants to a tested intervention. Its 3,200 participants enrollment target places it among the larger protocols in the corpus, above the 458-participant average among 188 other Smoking Cessation trials with a reported enrollment target (599% higher).
The record links to 3 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Refer2Quit is the first listed.
NCT06582693 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06582693 about?
NCT06582693 is a clinical study titled "Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network". The goal of this clinical trial is to compare the reach and effectiveness of the Refer2Quit intervention for increasing tobacco use treatment and quit rates among household members who smoke versus a treatment as usual group. This clinical trial also aims to study household member and pediatric pati...
What is the current status of trial NCT06582693?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,200 participants. The study started on 2024-09-06. Estimated completion is 2027-03-01.
What conditions does trial NCT06582693 study?
This clinical trial studies the following conditions: Smoking Cessation, Smoking, Second Hand Tobacco Smoke.
What interventions are being tested in trial NCT06582693?
The interventions under investigation include: Refer2Quit (OTHER).
Who is sponsoring clinical trial NCT06582693?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06582693 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06582693's enrollment target sits among peer trials
3,200 3rd of 188 higher than 186 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
-
Remote Smoking Cessation in Hospitalized Cardiac Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02043457 · 3,200 participants
Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance
- NCT04045665 · 3,200 participants · Phase 3
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- NCT05381766 · 3,200 participants · NA
Building Access to Food Through Systems and Solidarity
- NCT06042543 · 3,200 participants · NA
Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI